cabozantinib
ipsen
['rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabopoint', 'cabo ']
#gu23 terrific data from #cabopoint from - first prospective trial for cabo after 1l io - interim analyses shows orr with cabo regardless of prior therapy in patients with arcc after cpi-based combination therapy, irrespective 
GU Oncologist/Clinical Trials/ Experimental Therapeutics @UCD_Cancer @UCDavisHealth via @uofcincy @GoBEARCATS. Tweets= My opinions #RCC #ASCO #immunotherapy